WILD 5 Wellness: A 30-Day Intervention

The purpose of this study is to explore the efficacy and feasibility of an integrated, prescriptive, and trackable wellness intervention combining five wellness elements including exercise, mindfulness, sleep, social connectedness, and nutrition in Beloit College students. This program is called "WILD 5 Wellness: A 30-Day Intervention". Results for this study will be quantified through the use of standardized self-report questionnaires administered prior to and after students complete the WILD 5 program (Group 1) or 30 days of inactive participation (Group 2), and again approximately 30 days later when the initially inactive group (Group 2) will have just completed their active participation in the WILD 5 program and the first WILD 5 group (Group 1) will be approximately 30 days out from completion of their WILD 5 active portion. Data will be collected to evaluate participants' adherence and response to each element of WILD 5, a 5-pronged 30-day wellness intervention. It is expected that this 30-day integrated, prescriptive, and trackable program will be found to be an efficacious wellness intervention for Beloit College students as compared to the control (inactive) group of students not participating in the Active program.

Study Overview

• Status: Completed
• Conditions: Healthy
• Intervention / Treatment: Other: WILD 5 Wellness

• Study Type: Interventional
• Enrollment (Actual): 88
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Wisconsin
    • Beloit, Wisconsin, United States, 53511
      • Beloit College

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Beloit College student enrolled in one or more of the following Spring 2017 academic courses:
• Anthropology 201 01 "Research Designs: Sophomore Seminar in Anthropology"
• Health and Society 240 B1 "Sophomore Seminar in Health and Society"
• Spanish 218 "Health and Culture in the Spanish-Speaking World"
• Biology 373 "Neuroscience Research"
• Biology 215 "Emerging Diseases"

Exclusion Criteria:

• Individuals who are <18 years old
• Individuals who are acutely suicidal and/or actively psychotic
• Individuals who are pregnant or plan to get pregnant during the next 60 days, or who are not registered in one of the courses listed above.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Other: Group 1; Group 1 will be active in the WILD 5 Wellness program the first 30 days and inactive the 2nd 30 days.	Other: WILD 5 Wellness; Participants will be asked to voluntarily engage in integrated, prescriptive, and trackable wellness interventions combining five wellness elements including exercise, mindfulness, sleep, social connectedness, and nutrition.
Other: Group 2; Group 2 will be inactive in the WILD 5 Wellness program the first 30 days and active the 2nd 30 days.	Other: WILD 5 Wellness; Participants will be asked to voluntarily engage in integrated, prescriptive, and trackable wellness interventions combining five wellness elements including exercise, mindfulness, sleep, social connectedness, and nutrition.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
WILD 5 Wellness Scale (W5WS), Assessing Change	Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
WILD 5 Wellness Elements (W5WE), Assessing Change	Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
WILD 5 Wellness Effort Scale (W5WES), Assessing Change	Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
WHO (World Health Organization) 5 Well-Being Index (1998 version), Assessing Change	Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Social Connectedness Scale (SCS), Assessing Change	Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Sleep Condition Indicator (SCI), Assessing Change	Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Sheehan Disability Scale (SDS), Assessing Change	Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Patient Health Questionnaire (PHQ-9), Assessing Change	Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Mindful Attention Awareness Scale (MAAS), Day to Day Experiences, Assessing Change	Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
MIND ( Mediterranean-DASH Intervention for Neurodegenerative Delay)Diet, Assessing Change	Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Generalized Anxiety Disorder (GAD-7), Assessing Change	Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Eating and Appraisal Due to Emotions and Stress Questionnaire (EADES), Assessing Change	Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Cognitive and Physical Functioning Questionnaire (CPFQ), Assessing Change	Day 0, Day 30, Day 60, Day 30 + 6 months (Group 1), Day 60 + 6 months (Group 2)
Post Program Participant Questionnaire	The end of the 30 day active participation in WILD 5 Wellness for each group (1 and 2)

Collaborators and Investigators

• Sponsor: Beloit College

Study record dates

Study Major Dates

• Study Start (Actual): February 6, 2017
• Primary Completion (Actual): April 18, 2017
• Study Completion (Actual): December 5, 2017

Study Registration Dates

• First Submitted: January 17, 2017
• First Submitted That Met QC Criteria: January 19, 2017
• First Posted (Estimate): January 23, 2017

Study Record Updates

• Last Update Posted (Actual): April 26, 2018
• Last Update Submitted That Met QC Criteria: April 24, 2018
• Last Verified: April 1, 2018

More Information

Terms related to this study

• Other Study ID Numbers: 302

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No